Clinical Trial - Trial HKUCTR-2798
Access comprehensive clinical trial information for HKUCTR-2798 through Pure Global AI's free database. This Phase 2 trial is sponsored by Novocure GmbH and is currently Completed. The study focuses on Neoplasm.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to HKU CLINICAL TRIALS REGISTRY data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
HKUCTR-2798
Phase 2
Completed
Device Trial
device
Trial Details
HKU CLINICAL TRIALS REGISTRY • HKUCTR-2798
Untitled Trial
A Phase 2, Single Arm, Multi-center, Open-Label Trial to Evaluate the Safety and Efficacy of Treatment with Tumor Treating Fields (TTFields) and Chemotherapy as First-Line Treatment for Subjects with Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Gastric (GC) Adenocarcinoma.
Study Focus
Sponsor & Location
Novocure GmbH
China
Timeline & Enrollment
Phase 2
N/A
Dec 31, 2021
ICD-10 Classifications
Neoplasms
Benign neoplasms
In situ neoplasms
Personal history of other neoplasms
Benign neoplasm: Other specified sites
Data Source
HKU CLINICAL TRIALS REGISTRY
HKUCTR-2798
Device Trial